ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 228 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $4,122,000 | +251.4% | 77,106 | +218.6% | 0.33% | +178.3% |
| Q2 2020 | $1,173,000 | -86.7% | 24,201 | -90.1% | 0.12% | -74.6% |
| Q3 2019 | $8,825,000 | +771.2% | 245,234 | +546.8% | 0.47% | +1110.3% |
| Q2 2019 | $1,013,000 | +46.8% | 37,915 | +47.5% | 0.04% | -2.5% |
| Q1 2019 | $690,000 | -65.9% | 25,700 | -73.6% | 0.04% | -43.7% |
| Q3 2018 | $2,024,000 | +41.9% | 97,500 | +134.9% | 0.07% | +222.7% |
| Q1 2017 | $1,426,000 | -51.8% | 41,500 | -54.5% | 0.02% | -84.1% |
| Q2 2016 | $2,960,000 | +1025.5% | 91,200 | +1347.6% | 0.14% | +245.0% |
| Q2 2015 | $263,000 | -8.7% | 6,300 | -30.8% | 0.04% | -9.1% |
| Q4 2014 | $288,000 | -24.4% | 9,100 | -40.9% | 0.04% | -39.7% |
| Q3 2014 | $381,000 | -35.1% | 15,400 | -34.5% | 0.07% | +28.1% |
| Q4 2013 | $587,000 | – | 23,500 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |